Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MOXALACTAM

K-Number: K822866 · 1982-12-28

Decision Date1982-12-28
Product CodeJTT
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MOXALACTAM is the device name listed in this FDA 510(k) record. The listed applicant is Lilly Research Laboratories. It received FDA 510(k) clearance on 1982-12-28 under 510(k) number K822866. The device is classified under product code JTT. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MOXALACTAM?

MOXALACTAM is a medical device that received FDA 510(k) clearance on 1982-12-28. The listed applicant is Lilly Research Laboratories. The 510(k) number is K822866.

When did MOXALACTAM receive FDA 510(k) clearance?

MOXALACTAM received FDA 510(k) clearance on 1982-12-28, under 510(k) number K822866.

Who is the listed applicant for MOXALACTAM?

The FDA 510(k) record lists Lilly Research Laboratories as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MOXALACTAM?

The FDA product code for MOXALACTAM is JTT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Lilly Research Laboratories as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: JTT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑